Published in Synapse on October 01, 2009
Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl) (2011) 3.57
A reinforcement learning mechanism responsible for the valuation of free choice. Neuron (2014) 1.64
Dopaminergic genes predict individual differences in susceptibility to confirmation bias. J Neurosci (2011) 1.58
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev (2011) 1.00
A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Transl Psychiatry (2011) 0.97
Genetics of dopamine receptors and drug addiction. Hum Genet (2012) 0.89
Response inhibition and interference control in obsessive-compulsive spectrum disorders. Front Hum Neurosci (2014) 0.85
Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. Behav Brain Funct (2010) 0.83
Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing. Front Hum Neurosci (2013) 0.83
Valenced action/inhibition learning in humans is modulated by a genetic variant linked to dopamine D2 receptor expression. Front Syst Neurosci (2014) 0.83
Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies. Transl Psychiatry (2016) 0.80
Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms. Psychopharmacology (Berl) (2015) 0.80
Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology (2013) 0.80
PharmGKB summary: dopamine receptor D2. Pharmacogenet Genomics (2011) 0.78
DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol. Behav Brain Funct (2015) 0.78
Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes. PLoS One (2015) 0.78
The C957T polymorphism in the dopamine receptor D₂ gene modulates domain-general category learning. J Neurophysiol (2015) 0.78
Genetic variations in COMT and DRD2 modulate attentional bias for affective facial expressions. PLoS One (2013) 0.77
Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. Synapse (2016) 0.77
An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population. Cell Mol Neurobiol (2012) 0.77
New repeat polymorphism in the AKT1 gene predicts striatal dopamine D2/D3 receptor availability and stimulant-induced dopamine release in the healthy human brain. J Neurosci (2017) 0.76
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Schizophr Bull (2016) 0.76
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients. Eur J Clin Pharmacol (2016) 0.76
Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population. Int J Clin Exp Pathol (2013) 0.76
Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis. PLoS One (2015) 0.76
People are different: tyrosine's modulating effect on cognitive control in healthy humans may depend on individual differences related to dopamine function. Front Psychol (2014) 0.75
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia. Can J Psychiatry (2016) 0.75
The effect of COMT Val158Met and DRD2 C957T polymorphisms on executive function and the impact of early life stress. Brain Behav (2017) 0.75
Functional Polymorphisms in Dopaminergic Genes Modulate Neurobehavioral and Neurophysiological Consequences of Sleep Deprivation. Sci Rep (2017) 0.75
The ANKK1/DRD2 locus is a genomic substrate for affective priming and recognition of angry faces. Brain Behav (2015) 0.75
Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease. Int J Mol Sci (2017) 0.75
Lifespan Changes in the Countermanding Performance of Young and Middle Aged Adult Rats. Front Aging Neurosci (2016) 0.75
Behavioral and Neural Manifestations of Reward Memory in Carriers of Low-Expressing versus High-Expressing Genetic Variants of the Dopamine D2 Receptor. Front Psychol (2017) 0.75
Mediating Role of the Reward Network in the Relationship between the Dopamine Multilocus Genetic Profile and Depression. Front Mol Neurosci (2017) 0.75
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation (2006) 3.12
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet (2004) 2.91
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol (2012) 2.61
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc Natl Acad Sci U S A (2010) 2.32
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol (2008) 2.24
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol (2008) 2.19
A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging (2012) 2.18
Tailored anterior clinoidectomy through the lateral supraorbital approach: experience with 82 consecutive patients. World Neurosurg (2011) 2.17
The use of PET in Alzheimer disease. Nat Rev Neurol (2010) 2.13
Saccular intracranial aneurysm: pathology and mechanisms. Acta Neuropathol (2012) 2.09
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 2.09
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 2.04
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron (2003) 2.03
Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet (2008) 1.90
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation (2008) 1.82
Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery (2008) 1.73
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry (2005) 1.67
Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med (2010) 1.61
Binge drinking in midlife and dementia risk. Epidemiology (2005) 1.61
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci (2005) 1.58
Complications of anterior clinoidectomy through lateral supraorbital approach. World Neurosurg (2011) 1.57
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging (2008) 1.55
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse (2007) 1.46
Brain white matter expansion in human obesity and the recovering effect of dieting. J Clin Endocrinol Metab (2007) 1.46
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging (2009) 1.45
Microneurosurgical management of anterior choroid artery aneurysms. World Neurosurg (2010) 1.42
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry (2002) 1.37
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. Arch Neurol (2008) 1.31
Characteristics of two telephone screens for cognitive impairment. Dement Geriatr Cogn Disord (2002) 1.31
Effects of working-memory training on striatal dopamine release. Science (2011) 1.30
Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain (2003) 1.29
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry (2004) 1.28
Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc Natl Acad Sci U S A (2003) 1.27
Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol (2007) 1.27
Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol (2011) 1.21
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.21
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics (2005) 1.19
Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol (2004) 1.17
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord (2008) 1.15
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) (2005) 1.14
Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology (2008) 1.14
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology (2010) 1.13
Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain. Eur J Nucl Med Mol Imaging (2014) 1.11
Altered dopamine D2 receptor binding in atypical facial pain. Pain (2003) 1.10
Increased brain fatty acid uptake in metabolic syndrome. Diabetes (2010) 1.10
Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction. Neuroimage (2005) 1.10
Microscope-integrated near-infrared indocyanine green videoangiography during surgery of intracranial aneurysms: the Helsinki experience. Surg Neurol (2009) 1.09
Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry (2003) 1.08
Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry (2007) 1.08
Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer (2002) 1.07
Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain. Mol Imaging Biol (2006) 1.07
Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage (2012) 1.07
Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain. Synapse (2015) 1.05
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study. Mov Disord (2006) 1.05
Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev (2002) 1.04
Mobile phone affects cerebral blood flow in humans. J Cereb Blood Flow Metab (2006) 1.03
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease. Mov Disord (2004) 1.03
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab (2008) 1.02
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging (2005) 1.02
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J Clin Psychopharmacol (2002) 1.01
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab (2006) 1.00
C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.00
Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ). Mol Imaging Biol (2004) 1.00
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. J Nucl Med (2013) 1.00
Involvement of mitogen-activated protein kinase signaling in growth and rupture of human intracranial aneurysms. Stroke (2008) 0.99
Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail (2006) 0.98
Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation. J Alzheimers Dis (2008) 0.98
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry (2005) 0.97
Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. J Nucl Med (2007) 0.97
Effects of a 902 MHz mobile phone on cerebral blood flow in humans: a PET study. Neuroreport (2003) 0.97
Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects. Neuroimage (2008) 0.96
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol Aging (2012) 0.96
Midlife sleep characteristics associated with late life cognitive function. Sleep (2013) 0.96
Age-related loss of extrastriatal dopamine D(2) -like receptors in women. J Neurochem (2002) 0.96